CYP2C19 inhibition: the impact of substrate probe selection on in vitro inhibition profiles

RS Foti, JL Wahlstrom - Drug metabolism and disposition, 2008 - ASPET
Understanding the potential for cytochrome P450 (P450)-mediated drug-drug interactions is
a critical part of the drug discovery process. Factors such as nonspecific binding, atypical …
被引用次数：79 相关文章

[引用][C] CYP2C19 Inhibition: The Impact of Substrate Probe Selection on in Vitro Inhibition Profiles

RS Foti, JL Wahlstrom - Drug Metabolism and Disposition, 2007 - cir.nii.ac.jp
CYP2C19 Inhibition: The Impact of Substrate Probe Selection on in Vitro Inhibition Profiles |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …

CYP2C19 inhibition: the impact of substrate probe selection on in vitro inhibition profiles

RS Foti, JL Wahlstrom - Drug metabolism and disposition …, 2008 - pubmed.ncbi.nlm.nih.gov
Understanding the potential for cytochrome P450 (P450)-mediated drug-drug interactions is
a critical part of the drug discovery process. Factors such as nonspecific binding, atypical …

[引用][C] CYP2C19 Inhibition: The Impact of Substrate Probe Selection on in Vitro Inhibition Profiles

RS FOTI, JL WAHLSTROM - Drug metabolism and disposition, 2008 - pascal-francis.inist.fr
CYP2C19 Inhibition : The Impact of Substrate Probe Selection on in Vitro Inhibition Profiles
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple …

[引用][C] CYP2C19 Inhibition: The Impact of Substrate Probe Selection on In Vitro Inhibition Profiles

RS Foti, JL Wahlstrom - Drug Metabolism and Disposition, 2007 - ASPET
Understanding the potential for P450-mediated drug-drug interactions is a critical part of the
drug discovery process. Factors such as nonspecific binding, atypical kinetics, poor effector …

CYP2C19 inhibition: the impact of substrate probe selection on in vitro inhibition profiles.

RS Foti, JL Wahlstrom - … and Disposition: the Biological Fate of …, 2007 - europepmc.org
Understanding the potential for cytochrome P450 (P450)-mediated drug-drug interactions is
a critical part of the drug discovery process. Factors such as nonspecific binding, atypical …